TolerogenixX's Seed VC Round

TolerogenixX raised a round of funding on May 23, 2017. Investors include High-Tech Grunderfonds.

TolerogenixX has developed a patented and clinically tested cell therapy technique for individualized immunosuppression in transplant patients. The technique enables the targeted disabling of undesire…

Articles about TolerogenixX's Seed VC Round: